Initiative Targets Women Aged 45+ with Risk Assessments, Imaging, and Symptom-Based Screening
Bengaluru, July 30, 2025 — In a significant step towards enhancing preventive care for women, Apollo Cancer Centres (ACCs) have introduced End-O Check, an early screening and diagnosis program specifically aimed at detecting endometrial and ovarian cancers in their initial stages. The initiative primarily targets women aged 45 and above, with a particular focus on postmenopausal individuals.
The program offers a combination of risk-based evaluations, diagnostic testing, and symptom analysis to identify two of the most commonly occurring gynecological cancers—endometrial and ovarian—at a stage when treatment is more effective.
Ovarian Cancer Often Diagnosed Too Late
Ovarian cancer, often known as the “silent killer,” typically affects women between the ages of 55 and 64, with the average age of diagnosis being 63. When identified early, the five-year survival rate exceeds 90%, underscoring the critical importance of timely screening.
Cancer Burden on the Rise in India
India is expected to see its total cancer cases rise to 1.52 million by 2025. Among these, ovarian and uterine cancers remain in the top five most common cancers affecting women. Current data estimates the age-standardized incidence rate at 45 per 100,000 for ovarian cancer and 25 per 100,000 for endometrial cancer. Experts attribute this growing trend to changes in reproductive behavior, increasing urbanization, and a rise in lifestyle-related and metabolic disorders.
Delayed Reporting Leads to Poorer Outcomes
While endometrial cancer often presents with warning signs such as abnormal bleeding or unusual discharge, many women fail to seek medical attention promptly. This results in delayed diagnosis and reduced survival rates. End-O Check aims to address this gap through public awareness and early intervention.
Experts Emphasize Timely Detection
At the launch, Mr. Dinesh Madhavan, President, Group Oncology & International, Apollo Hospitals Enterprise Ltd., stated, “Early detection remains our strongest ally in improving survival and quality of life. End-O Check marks a proactive shift towards screening and prevention, enabling prompt diagnosis and precision treatment.”
Dr. Rani Bhat, Senior Consultant – Gynae Oncology, Apollo Cancer Centre, Bengaluru, noted, “We are witnessing a steady rise in endometrial cancer cases. Early detection significantly improves prognosis, with global survival rates for localized disease around 96%. However, delayed diagnosis leads to poor outcomes. Factors like obesity, diabetes, early menstruation, late menopause, and PCOS are contributing to rising incidence rates in India.”
Dr. Aruna R Patil, Senior Consultant and Head – Radiology Department, Apollo Cancer Centre, Bengaluru, added, “Radiology plays a vital role in early cancer detection. Through End-O Check, we are implementing transvaginal ultrasonography (TVS) to detect subtle abnormalities in the uterus and ovaries, allowing for earlier intervention and better patient outcomes.”
A Step Toward Empowering Women’s Health
By promoting early screening and symptom awareness, End-O Check empowers women to take a proactive role in managing their gynecologic health. Apollo Cancer Centres aim to significantly reduce late-stage cancer diagnoses and improve survival rates among Indian women through this initiative.
City Today News 9341997936
City Today News 